Provider Resources WA

01/06/22 Health Advisory: Booster Eligibility Expanded

Syringe in vial

COVID-19 Updates for Providers Requested actions Be aware, Centers for Disease Control and Prevention (CDC) endorsed Advisory Committee on Immunization Practices’ (ACIP’s) decision to strongly recommend a single Pfizer COVID-19 vaccine booster dose for people 12–17 years old at least 5 months after their primary series. This expands the age of booster access and strengthens 01/06/22 Health Advisory: Booster Eligibility Expanded

01/04/22 Health Advisory: CDC updated antiviral guidance

Exam room with vitals equipment on wall

COVID-19 Updates for Providers Requested actions Be aware, Centers for Disease Control and Prevention (CDC) updated its COVID-19 monoclonal antibody treatment recommendations. Sotrovimab monoclonal antibody formulation retains significant efficacy against Omicron, the dominant circulating variant. Other monoclonal antibody formulations under emergency use authorization (EUA)—bamlanivimab and etesevimab and casirivimab and imdevimab—lack clinical benefit against Omicron and 01/04/22 Health Advisory: CDC updated antiviral guidance

12/22/21 Health Advisory: Paxlovid granted EUA and Testing before gathering

COVID-19 Updates for Providers Requested actions Be aware, Food and Drug Administration (FDA) granted emergency use authorization (EUA) to the first oral antiviral treatment for COVID-19, Pfizer’s Paxlovid. The EUA comes after research showed Paxlovid was nearly 90% effective at preventing hospitalization and death in people 12 years or older at high risk of severe 12/22/21 Health Advisory: Paxlovid granted EUA and Testing before gathering

12/13/21 Health Advisory: COVID-19 Updates for Providers

COVID-19 Updates for Providers Requested actions Be aware, Centers for Disease Control and Prevention (CDC) and Western States Scientific Safety Review Workgroup recommend everyone 16 years or older get a COVID-19 vaccine booster dose at the recommended interval. This recommendation comes after Food and Drug Administration (FDA) expanded its emergency use authorization (EUA) for Pfizer-BioNTech 12/13/21 Health Advisory: COVID-19 Updates for Providers

12/03/21 Health Advisory: COVID-19 Updates for Providers

COVID-19 Updates for Providers Requested actions Be aware, Centers for Disease Control and Prevention (CDC) issued a health advisory warning of COVID-19 variant of concern Omicron (B.1.1.529). At least one case has been identified in the U.S.; it was linked to travel. Omicron has not been detected in Pierce County; however, we are tracking its 12/03/21 Health Advisory: COVID-19 Updates for Providers

11/23/21 Health Advisory: COVID-19 vaccine booster doses available to everyone 18 years or older

Syringe in vial

COVID-19 Updates for Providers Requested actions Be aware, following the Food and Drug Administration’s (FDA’s) decision to update its emergency use authorizations (EUAs) to allow COVID-19 vaccine booster doses for everyone 18 years or older, Centers for Disease Control and Prevention (CDC) and Western States Scientific Safety Review Workgroup recommend: People 50 years or older 11/23/21 Health Advisory: COVID-19 vaccine booster doses available to everyone 18 years or older

Pertussis Fact Sheet

Stethoscope on child's back

To report a confirmed or suspect case of pertussis, complete the or call . Overview Pertussis is common and very contagious. It is caused by Bordetella pertussis. The bacteria infect cilia in the upper respiratory tract. Early symptoms are mild, like the common cold. Patients often experience violent coughing fits (paroxysms). These can be followed by Pertussis Fact Sheet

Hepatitis A Fact Sheet

Gloved hand squeeze bicep while giving a shot.

Overview Transmission: Fecal-oral. Incubation Period: Average 28-30 days (range 15-50 days). Symptoms: Anorexia, vomiting, abdominal pain, fatigue, followed by jaundice. Severity of illness increases with age. Infectious Period: 14 days prior to onset of jaundice to seven days after onset of jaundice. Infants can excrete virus in the stool for longer periods of time. Epidemiology: Hepatitis A Fact Sheet

Health Advisory: Zika Testing

Action Requested Know how to order appropriate Zika virus testing through commercial laboratories. Background Because testing for Zika virus is now widely available through commercial laboratories, testing for Zika virus at Washington State Public Health Laboratories is now limited to: Patients for whom cost is a barrier to testing. Infants with possible congenital exposure to Health Advisory: Zika Testing

Hand Hygiene In Healthcare Settings

Pair of hands lathering soap over a steel sink

What is hand hygiene? Hand hygiene refers to the use of hand washing with soap and water or alcohol hand sanitizer (60% alcohol or greater) in order to reduce infection rates, reduce transmission of antimicrobial resistant organisms and stop outbreaks of communicable disease. Why is hand hygiene important? When should I use hand hygiene? How Hand Hygiene In Healthcare Settings